Free Webex Call
The Global Optical Genome Mapping Market stood at USD101.11 Million in 2021 and is projected to grow at a CAGR of 19.73% during the forecast period. Optical genome mapping represents an emerging technology that utilizes labeled and high molecular weight DNA that is subsequently electrophoresed to nanochannels and linearized for imaging. Optical mapping has been commonly used to enhance de novo plant genome assemblies, with more genomes in the pipeline, such as rice, maize, Medicago, Amborella, tomato, and wheat. Optical genome mapping provides long-range genomic information and makes it convenient to spot significant structural differences. Optical mapping can assess long single DNA molecules that complement short-read sequencing. This technology assists in eliminating and finding out the cause of several genetic disorders in the plants and getting information about the root cause of those genetic disorders. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The modifying lifestyle, along with the accumulation of harmful mutations, escalates the cases of genetic disorders, which drives the market growth. The rising awareness among the population related to prenatal testing has elevated the demand for techniques such as optical genome mapping. Optical genome mapping assists in identifying repeat sections of the genome and all varieties of structural variants, thereby having the edge over the existing sequencing technologies. All these factors aid in market growth.
The Global Optical Genome Mapping Market is segmented by product, application, end-user, regional distribution, and competitive landscape. Based on product, the market can be split into consumables and instruments. Based on application, the market can be divided into genome assembly, structural variation detection, microbial strain typing, haplotype phasing, and others. Based on end-user, the market can be segmented into research & academic institutions, biotechnology & pharmaceutical companies, clinical laboratories, and others. Regionally, the market is divided into Asia-Pacific region, North America, Europe, South America, and Middle East & Africa.
The leading market players are Bionano Genomics, Inc., Nabsys Inc, Nucleome Informatics Pvt Ltd, France Génomique, Praxis Genomics LLC, PerkinElmer, Inc., and OpGen, Inc.
Years considered for this report:
- Historical Years: 2017-2020
- Base Year: 2021
- Estimated Year: 2022
- Forecast Period: 2023-2027
Objective of the Study:
- To analyze the historical growth of the market size of the Global Optical Genome Mapping Market from 2017 to 2021.
- To estimate and forecast the market size of the Global Optical Genome Mapping Market from 2022 to 2027 and growth rate until 2027.
- To classify and forecast the Global Optical Genome Mapping Market based on product, application, end-user, regional distribution, and competitive landscape.
- To identify dominant region or segment in the Global Optical Genome Mapping Market.
- To identify drivers and challenges for the Global Optical Genome Mapping Market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Optical Genome Mapping Market.
- To identify and analyze the profile of leading players operating in the Global Optical Genome Mapping Market.
- To identify key sustainable strategies adopted by the market players in the Global Optical Genome Mapping Market.
The publisher calculated the Global Optical Genome Mapping Market size by using a bottom-up approach, where data for various end-user industries and its application across various product types were recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used.
Key Target Audience:
- Optical genome mapping companies/partners
- End-users
- Government bodies such as regulating authorities and policy makers
- Organizations, industry associations, forums and alliances related to optical genome mapping
- Market research and consulting firms
Report Scope:
In this report, the Global Optical Genome Mapping Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Optical Genome Mapping Market, By Product:
- Consumables
- Instruments
Optical Genome Mapping Market, By Application:
- Genome Assembly
- Structural Variation Detection
- Microbial Strain Typing
- Haplotype Phasing
- Others
Optical Genome Mapping Market, By End-User:
- Research & Academic Institutions
- Biotechnology & Pharmaceutical Companies
- Clinical Laboratories
- Others
Optical Genome Mapping Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Germany
- Spain
- Italy
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Global
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Optical Genome Mapping Market.
Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.
Table of Contents
1. Product Overview2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Optical Genome Mapping Market
5. Voice of Customer
5.1. Optical Genome Mapping Awareness
5.2. Brand Awareness
5.3. Factors Contributing Switch to Optical Genome Mapping
6. Global Optical Genome Mapping Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumables v/s Instruments)
6.2.2. By Application (Genome Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype Phasing, Others)
6.2.3. By End User (Research & Academic Institutions, Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Others)
6.2.4. By Region
6.2.5. By Company (2021)
6.3. Market Map (By Product, By Application, By End User, By Region)
7. North America Optical Genome Mapping Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Optical Genome Mapping Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Canada Optical Genome Mapping Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. Mexico Optical Genome Mapping Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By End User
8. Europe Optical Genome Mapping Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Optical Genome Mapping Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. United Kingdom Optical Genome Mapping Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Germany Optical Genome Mapping Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. Italy Optical Genome Mapping Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Spain Optical Genome Mapping Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. Asia-Pacific Optical Genome Mapping Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Optical Genome Mapping Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. India Optical Genome Mapping Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Japan Optical Genome Mapping Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By End User
9.3.4. South Korea Optical Genome Mapping Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Application
9.3.4.2.3. By End User
9.3.5. Australia Optical Genome Mapping Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Application
9.3.5.2.3. By End User
10. South America Optical Genome Mapping Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Optical Genome Mapping Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Argentina Optical Genome Mapping Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. Colombia Optical Genome Mapping Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Middle East and Africa Optical Genome Mapping Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Application
11.2.3. By End User
11.2.4. By Globe
11.3. Middle East and Africa: Country Analysis
11.3.1. South Africa Optical Genome Mapping Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Application
11.3.1.2.3. By End User
11.3.2. Saudi Arabia Optical Genome Mapping Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Application
11.3.2.2.3. By End User
11.3.3. UAE Optical Genome Mapping Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Application
11.3.3.2.3. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
14.2.1. Bionano Genomics, Inc.
14.2.2. Nabsys Inc
14.2.3. Nucleome Informatics Pvt Ltd
14.2.4. France Génomique
14.2.5. Praxis Genomics LLC
14.2.6. PerkinElmer, Inc.
14.2.7. OpGen, Inc.
15. Strategic RecommendationsList of FiguresFigure 1: Global Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 3: Global Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 4: Global Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 5: Global Optical Genome Mapping Market Share, By Region, By Value, 2017-2027F
Figure 6: Global Optical Genome Mapping Market Share, By Company, By Value, 2021
Figure 7: Global Optical Genome Mapping Market Map, By Product, Market Size (USD Million) & Growth Rate (%), 2021
Figure 8: Global Optical Genome Mapping Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: Global Optical Genome Mapping Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: Global Optical Genome Mapping Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: North America Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 12: North America Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 13: North America Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 14: North America Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 15: North America Optical Genome Mapping Market Share, By Globe, By Value, 2017-2027F
Figure 16: United States Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 17: Total Human Genome Project Funding By National Institutes for Health in United States (USD Million), 2017-2021
Figure 18: United States Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 19: United States Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 20: United States Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 21: Canada Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 22: Death Rate for Congenital Malformations, Deformations and Chromosomal Abnormalities in Canada (Per 100, 000 population), 2017-2021
Figure 23: Canada Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 24: Canada Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 25: Canada Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 26: Mexico Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 27: Mexico Research and Development Expenditure As a Percentage of GDP, 2017-2021
Figure 28: Mexico Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 29: Mexico Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 30: Mexico Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 31: Europe Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 32: Europe Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 33: Europe Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 34: Europe Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 35: Europe Optical Genome Mapping Market Share, By Globe, By Value, 2017-2027F
Figure 36: France Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 37: Number of Physicians Specializing in Medical Genetics in France in 2020, By Region
Figure 38: France Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 39: France Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 40: France Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 41: United Kingdom Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 42: Number of Companies in the Life Science Industry Sector in the United Kingdom, By Sector, 2020
Figure 43: United Kingdom Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 44: United Kingdom Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 45: United Kingdom Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 46: Germany Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 47: Germany Healthcare Expenditure, By Value (USD Billion), 2017-2020
Figure 48: Germany Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 49: Germany Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 50: Germany Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 51: Italy Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 52: Number of Cystic Fibrosis Patients in Italy, By Age, As of January 2020
Figure 53: Italy Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 54: Italy Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 55: Italy Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 56: Spain Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 57: Number of Individuals Suffering from Alzheimer’s Disease in Spain, 2020, 2025, 2030, 2035, 2040
Figure 58: Spain Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 59: Spain Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 60: Spain Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 61: Asia-Pacific Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 62: Asia-Pacific Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 63: Asia-Pacific Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 64: Asia-Pacific Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 65: Asia-Pacific Optical Genome Mapping Market Share, By Globe, By Value, 2017-2027F
Figure 66: China Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 67: Internal Research & Development Spending in China, (USD Billion), 2017-2021
Figure 68: China Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 69: China Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 70: China Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 71: India Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 72: Number of Hospitals in India, As of April 2020
Figure 73: India Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 74: India Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 75: India Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 76: Japan Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 77: Percentage of People Aged 65 years and older among Total Population in Japan, 2017-2021
Figure 78: Japan Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 79: Japan Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 80: Japan Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 81: South Korea Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 82: South Korea National Health Expenditure as a Percent of GDP, 2017-2020
Figure 83: South Korea Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 84: South Korea Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 85: South Korea Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 86: Australia Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 87: Most Prevalent Chronic Conditions Experienced in Australia, 2020-2021
Figure 88: Australia Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 89: Australia Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 90: Australia Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 91: South America Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 92: South America Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 93: South America Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 94: South America Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 95: South America Optical Genome Mapping Market Share, By Globe, By Value, 2017-2027F
Figure 96: Brazil Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 97: Total Medical Genetics Workforce in Brazil, 2020
Figure 98: Brazil Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 99: Brazil Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 100: Brazil Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 101: Argentina Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 102: Hospital Infrastructure in Argentina (In Thousands), By Type, 2022
Figure 103: Argentina Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 104: Argentina Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 105: Argentina Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 106: Colombia Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 107: Colombia Total Healthcare Expenditure (USD Billion), 2017-2021
Figure 108: Colombia Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 109: Colombia Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 110: Colombia Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 111: Middle East & Africa Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 112: Middle East & Africa Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 113: Middle East & Africa Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 114: Middle East & Africa Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 115: Middle East & Africa Optical Genome Mapping Market Share, By Globe, By Value, 2017-2027F
Figure 116: South Africa Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 117: Total Population of South Africa, 2017-2021 (in 1,000s)
Figure 118: South Africa Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 119: South Africa Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 120: South Africa Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 121: Global Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 122: Global Geriatric Population (Aged 65 & Above) As a Percent of Total Population, 2016-2020
Figure 123: Global Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 124: Global Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 125: Global Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 126: UAE Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 127: UAE Outpatient Healthcare Expenditure (USD Billion), 2017-2021
Figure 128: UAE Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 129: UAE Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 130: UAE Optical Genome Mapping Market Share, By End User, By Value, 2017-2027FList of TablesTable 1: Global Cancer Statistics, 2020
Table 2: Total Number of New Cancer Cases and Deaths Reported Globally, By Type, 2020
Table 3: North America Cancer Statistics, 2020
Table 4: Total Number of New Cancer Cases and Deaths Reported in North America, By Type, 2020
Table 5: Europe Cancer Statistics, 2020
Table 6: Total Number of New Cancer Cases and Deaths Reported in Europe, By Type, 2020
Table 7: Asia-Pacific Cancer Statistics, 2020
Table 8: Total Number of New Cancer Cases and Deaths Reported in Asia-Pacific, By Type, 2020
Table 9: South America Cancer Statistics, 2020
Table 10: Total Number of New Cancer Cases and Deaths Reported in South America, By Type, 2020
Table 11: Middle East & Africa Cancer Statistics, 2020
Table 12: Total Number of New Cancer Cases and Deaths Reported in Middle East, By Type, 2020
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bionano Genomics, Inc.
- Nabsys Inc
- Nucleome Informatics Pvt Ltd
- France Génomique
- Praxis Genomics LLC
- PerkinElmer, Inc.
- OpGen, Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 205 |
| Published | June 2022 |
| Forecast Period | 2017 - 2027 |
| Estimated Market Value ( USD | $ 59.97 Million |
| Forecasted Market Value ( USD | $ 288.33 Million |
| Compound Annual Growth Rate | 17.0% |
| Regions Covered | Global |
